Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Adams D, Lozeron P, Theaudin M, Mincheva Z, Cauquil C, Adam C, Signate A, Vial C, Maisonobe T, Delmont E, Franques J, Vallat JM, Sole G, Pereon Y, Lacour A, Echaniz-Laguna A, Misrahi M, Lacroix C; French Network for FAP. Adams D, et al. Amyloid. 2012 Jun;19 Suppl 1:61-4. doi: 10.3109/13506129.2012.685665. Amyloid. 2012. PMID: 22620968
[Autonomic peripheral neuropathy].
Adams D, Cauquil C, Lozeron P. Adams D, et al. Presse Med. 2012 Nov;41(11):1128-36. doi: 10.1016/j.lpm.2012.05.030. Epub 2012 Sep 27. Presse Med. 2012. PMID: 23021660 Review. French.
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB. Coelho T, et al. Among authors: adams d. N Engl J Med. 2013 Aug 29;369(9):819-29. doi: 10.1056/NEJMoa1208760. N Engl J Med. 2013. PMID: 23984729 Free article. Clinical Trial.
FAP neuropathy and emerging treatments.
Adams D, Théaudin M, Cauquil C, Algalarrondo V, Slama M. Adams D, et al. Curr Neurol Neurosci Rep. 2014 Mar;14(3):435. doi: 10.1007/s11910-013-0435-3. Curr Neurol Neurosci Rep. 2014. PMID: 24482069 Review.
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS. Adams D, et al. Expert Rev Neurother. 2014 Dec;14(12):1437-51. doi: 10.1586/14737175.2014.983905. Epub 2014 Nov 21. Expert Rev Neurother. 2014. PMID: 25416603 Review.
5,794 results